ÂÜÀòÂÒÂ×

Yang Xu is a seasoned professional with extensive experience in cancer research and biotechnology development, currently serving as a Senior Scientist and Principal Investigator at Geneseeq Technology Inc. since January 2019. Prior experience includes roles as a Marketing Intern at ALM Corp. and Raddle, where market analyses and marketing strategies were developed, and a Research and Development Intern at Perception Neuroscience, contributing to drug application preparations for the FDA. Early academic involvement as a Research Assistant at the University of Ottawa focused on protein activity under stress conditions. Yang Xu holds a PhD from both the University of Toronto and New York University in cancer research, along with an MBA from Quantic School of Business and Technology and an Honours Bachelor of Science from the University of Ottawa.